AZACTAM Powder for solution for injection or infusion Ref.[8665] Active ingredients: Aztreonam

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Bristol-Myers Squibb Pharmaceuticals Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH

Product name and form

Azactam 1 g Powder for Solution for Injection or Infusion.

Azactam 2 g Powder for Solution for Injection or Infusion.

Pharmaceutical Form

Powder for solution for injection or infusion.

Qualitative and quantitative composition

Each vial contains 1 g aztreonam.

Each vial contains 2 g aztreonam.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Aztreonam

Aztreonam exhibits activity in vitro against gram-negative aerobic pathogens, including P. aeruginosa. Aztreonam binds to penicillin-binding proteins of susceptible bacteria, which leads to inhibition of bacterial cell wall synthesis, followed by filamentation and cell lysis.

List of Excipients

L-arginine (780 mg per g of aztreonam)

Pack sizes and marketing

Type III clear molded glass vials, closed with silicone grey butyl rubber closure, and sealed with aluminium seal with flip off plastic button:

1 g glass vials: pack of 1 × 15 mL

2 g glass vials: pack of 1 × 15 mL

Marketing authorization holder

Bristol-Myers Squibb Pharmaceuticals Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH

Marketing authorization dates and numbers

Azactam 1 g vial: PL 11184/0134

Azactam 2 g vial: PL 11184/0135

15th October 1986 / 22nd November 1991 / 13th August 1998

Drugs

Drug Countries
AZACTAM Austria, Spain, Finland, France, Ireland, Japan, Malta, New Zealand, Singapore, United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.